Literature DB >> 9700672

Further evidence that Cerebrolysin protects cortical neurons from neurodegeneration in vitro.

B Hutter-Paier1, E Grygar, M Frühwirth, I Temmel, M Windisch.   

Abstract

The effects of Cerebrolysin on isolated chicken cortical neurons in an iron induced oxidative stress model and in a combined iron-glutamate model have been examined. In a first part of experiments it has been shown that under low serum conditions exposure of neurons to different concentrations of ammonium-iron (III)citrate (1, 5 microM AC-Fe3+) for 8 days caused a significant reduction in neuronal survival. Cerebrolysin not only prevented iron induced neurodegeneration, demonstrating that ionic iron was responsible for the cell damage, moreover, it increased the neuronal viability up to tenfold with respect to the controls. In the second part of the study neurons pre-incubated for 8 days with AC-Fe3+ were additionally lesioned with 1 mM L-glutamate and allowed to recover for another 48 h. Under these conditions cerebrolysin again clearly counteracted the in vitro destructive effects of glutamate. Besides consequences on the viability and survival of neurons Cerebrolysin increased abundance of the microtubule-associated protein MAP2, which is known to play a an important role in maintaining normal neuronal function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9700672     DOI: 10.1007/978-3-7091-6467-9_32

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  8 in total

1.  Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia.

Authors:  Rubén Antonio Vázquez-Roque; Brenda Ramos; Carolina Tecuatl; Ismael Juárez; Anthony Adame; Fidel de la Cruz; Sergio Zamudio; Raúl Mena; Edward Rockenstein; Eliezer Masliah; Gonzalo Flores
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

2.  A peptide preparation protects cells in organotypic brain slices against cell death after glutamate intoxication.

Authors:  C Riley; B Hutter-Paier; M Windisch; E Doppler; H Moessler; R Wronski
Journal:  J Neural Transm (Vienna)       Date:  2005-04-22       Impact factor: 3.575

3.  In vitro models of brain ischemia: the peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death.

Authors:  Birgit Gutmann; Birgit Hutter-Paier; Gerhard Skofitsch; Manfred Windisch; Rudolf Gmeinbauer
Journal:  Neurotox Res       Date:  2002-02       Impact factor: 3.911

4.  A multimodal pharmacological agent in combination with recanalization therapy (thrombolysis and thrombectomy) in severe stroke patients.

Authors:  Zdravka Poljakovic; Josip Ljevak; Svjetlana Supe; Katarina Starcevic
Journal:  J Med Life       Date:  2019 Oct-Dec

Review 5.  Role and Impact of Cerebrolysin for Ischemic Stroke Care.

Authors:  Dafin F Mureșanu; Livia Livinț Popa; Diana Chira; Victor Dăbală; Elian Hapca; Irina Vlad; Vitalie Văcăraș; Bogdan Ovidiu Popescu; Răzvan Cherecheș; Ștefan Strilciuc; Michael Brainin
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

6.  Cerebrolysin administration reduces oxidative stress-induced apoptosis in lymphocytes from healthy individuals.

Authors:  Patrizia Formichi; Elena Radi; Carla Battisti; Giuseppe Di Maio; Dafin Muresanu; Antonio Federico
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

Review 7.  Towards a roadmap in brain protection and recovery.

Authors:  Dafin F Muresanu; Anca Buzoianu; Stefan I Florian; Tobias von Wild
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

8.  Sera from children with autism induce autistic features which can be rescued with a CNTF small peptide mimetic in rats.

Authors:  Syed Faraz Kazim; Maria Del Carmen Cardenas-Aguayo; Mohammad Arif; Julie Blanchard; Fatima Fayyaz; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.